Depression, towards non-hallucinogenic therapies: new developments from Italian research
23.03.2026
A research group led by the University of Padua has developed new variants of psilocin, the active compound derived from psychedelic mushrooms, with the aim of treating depression and other mental disorders while limiting hallucinogenic effects


